Christine Marie Utter Ptc Therapeutics, Inc. (PTCT) insider trading activity

Christine Marie Utter is SVP, CHIEF ACCOUNTING OFFICER of PTC THERAPEUTICS, INC.. Currently has a direct ownership of 52,428 shares of PTCT, which is worth approximately $1.95 Million. The most recent transaction as insider was on Feb 15, 2024, when has been sold 16,900 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52.4K

0% 3M change

37.75% 12M change

Total Value Held $1.95 Million

Christine Marie Utter Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 15 2024	BUY Grant, award, or other acquisition	-	16,900 Added 24.38%	52,428 Common Stock
Jan 30 2024	SELL Open market or private sale	$8,665 $27.25 p/Share	318 Reduced 0.89%	35,528 Common Stock
Jan 09 2024	SELL Open market or private sale	$47,953 $29.01 p/Share	1,653 Reduced 4.41%	35,846 Common Stock
Jan 08 2024	SELL Open market or private sale	$34,024 $28.64 p/Share	1,188 Reduced 3.07%	37,499 Common Stock
Apr 21 2023	SELL Open market or private sale	$259,279 $55.26 p/Share	4,692 Reduced 10.98%	38,059 Common Stock
Apr 21 2023	BUY Exercise of conversion of derivative security	$154,929 $33.02 p/Share	4,692 Added 10.88%	38,430 Common Stock
Mar 29 2023	SELL Open market or private sale	$224,039 $47.79 p/Share	4,688 Reduced 10.97%	38,059 Common Stock
Mar 29 2023	BUY Exercise of conversion of derivative security	$189,629 $40.45 p/Share	4,688 Added 9.88%	42,747 Common Stock
Mar 27 2023	SELL Open market or private sale	$1,209,473 $45.37 p/Share	26,658 Reduced 41.19%	38,059 Common Stock
Mar 27 2023	BUY Exercise of conversion of derivative security	$880,247 $33.02 p/Share	26,658 Added 35.81%	47,788 Common Stock
Jan 31 2023	SELL Open market or private sale	$14,829 $45.63 p/Share	325 Reduced 0.85%	38,059 Common Stock
Jan 11 2023	SELL Open market or private sale	$18,498 $44.36 p/Share	417 Reduced 1.07%	38,384 Common Stock
Jan 10 2023	SELL Open market or private sale	$20,992 $42.93 p/Share	489 Reduced 1.24%	38,801 Common Stock
Jan 09 2023	SELL Open market or private sale	$29,411 $41.66 p/Share	706 Reduced 1.77%	39,290 Common Stock
Jan 05 2023	BUY Grant, award, or other acquisition	-	14,000 Added 25.93%	39,996 Common Stock
Feb 02 2022	SELL Open market or private sale	$28,549 $40.38 p/Share	707 Reduced 2.71%	25,405 Common Stock
Feb 01 2022	SELL Open market or private sale	$12,520 $40.0 p/Share	313 Reduced 1.18%	26,112 Common Stock
Jan 18 2022	SELL Open market or private sale	$499,975 $43.75 p/Share	11,428 Reduced 30.19%	26,425 Common Stock
Jan 18 2022	BUY Exercise of conversion of derivative security	$180,100 $18.01 p/Share	10,000 Added 21.54%	36,425 Common Stock
Jan 07 2022	SELL Open market or private sale	$28,774 $38.52 p/Share	747 Reduced 4.39%	16,253 Common Stock
Jan 07 2022	BUY Grant, award, or other acquisition	-	11,600 Added 29.4%	27,853 Common Stock
Feb 08 2021	SELL Open market or private sale	$175,362 $66.0 p/Share	2,657 Reduced 13.86%	16,509 Common Stock
Feb 08 2021	BUY Exercise of conversion of derivative security	$87,734 $33.02 p/Share	2,657 Added 12.18%	19,166 Common Stock
Feb 02 2021	SELL Open market or private sale	$37,581 $57.64 p/Share	652 Reduced 3.8%	16,509 Common Stock
Feb 01 2021	SELL Open market or private sale	$20,961 $56.96 p/Share	368 Reduced 2.1%	17,161 Common Stock

CMU

Christine Marie Utter

SVP, CHIEF ACCOUNTING OFFICER

South Plainfield, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTCT shares.

Notify only if

Value

Insider Trading

Get notified when an Ptc Therapeutics, Inc. insider buys or sells PTCT shares.

Notify only if

Operation

Value

Type

News

Receive news related to PTC THERAPEUTICS, INC.

Track Activities on PTCT

Account